Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Entinostat with Chemotherapy in Advanced NSCLC
NCT01935947Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine, entinostat in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started May 2013; status: terminated.
02
Drugs
azacitidineentinostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01935947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935947.